Ningbo Menovo Pharmaceutical Co., Ltd.
SHH: 603538.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Cheng Zhi Yao
- Employees
- 2,353
- Headquarters
- Ningbo, China
- IPO year
- 2017
- Market cap
- CN¥14.8B
- Website
- https://www.menovopharm.com
Loading 603538…
Loading profile data…Frequently asked questions about 603538
What does Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) do?
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headq...
Where does 603538.SS trade?
Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) trades on the Shanghai Stock Exchange.
What sector is 603538.SS in?
Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ningbo Menovo Pharmaceutical Co., Ltd.?
Cheng Zhi Yao is the chief executive officer of Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS).
Where is Ningbo Menovo Pharmaceutical Co., Ltd. headquartered?
Ningbo Menovo Pharmaceutical Co., Ltd. is headquartered in China.
Does 603538.SS pay a dividend?
Yes — Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) paid a trailing twelve-month dividend of CNY 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603538.SS go public?
Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) completed its initial public offering in 2017.